Name | P-gp inhibitor 1 |
---|
Description | P-gp inhibitor 1 is a novel inhibitor reversing P-glycoprotein-mediated multidrug resistance. |
---|---|
Related Catalog | |
Target |
P-glycoprotein[1] |
In Vitro | P-gp inhibitor 1 (12k) possesses high potency (EC50=57.9±3.5 nM), low cytotoxicity, and long duration of activity in reversing doxorubicin (DOX) resistance in K562/A02 cells (1 μM, 80 minutes)[1]. P-gp inhibitor 1 also boosts the potency of other MDR-related cytotoxic agents with different structures, increases accumulation of DOX, blocks Pgp-mediated Rh123 efflux, and suppresses P-gp ATPase activity in K562/A02 MDR cells (0.1, 1, 5 μM, 1 hour)[1]. Western Blot Analysis[1] Cell Line: K562/A02 cell Concentration: 0.1, 0.5, or 2.0 μM Incubation Time: 72 hours Result: MDR reversal by 12k was not caused by a decreased protein expression but instead most likely due to direct inhibition of P-gp efflux[1]. |
References |
Molecular Formula | C32H31N5O2 |
---|---|
Molecular Weight | 517.62 |